Lil­ly to buy Eu­ro­pean ADC biotech; Ab­b­Vie ends SHP2 work with Ja­co­bio

Eli Lil­ly ac­quired all shares of Emer­gence Ther­a­peu­tics, Hei­del­berg Phar­ma said last week.

The Ger­man phar­ma­ceu­ti­cal com­pa­ny was a mi­nor share­hold­er in Emer­gence, a biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.